Petros Pharmaceuticals(PTPI)
NEW YORK, NYPharmaceutical
Focus: Petros Pharmaceuticals is a publicly traded biotech company focused on men's health and neurology, founded in 2021 and headquartered in New York. The company operates at a pre-revenue or early commercialization stage with minimal cash reserves.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Petros Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Petros Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Petros Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$6M
FY2024
Pipeline & Clinical Trials
Cold environment participants with spinal cord injury
Spinal Cord InjuriesClinical Trials (1)
NCT04215939Assessment of Vasomotion of People With Spinal Cord Injury
N/AHelp build intelligence for Petros Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.